What is AB 606, and Why Do We Need It?

The manufacturers of the blockbuster drugs Vioxx and Celebrex knew their drugs caused serious heart damage for several years before the information was revealed, resulting in many deaths.

The clinical studies of drugs are carried out by the drug companies themselves, so even the medical researchers who write medical journal articles evaluating the drugs cannot be sure they are being given all the data on clinical studies that were done.

AB 606 would require pharmaceutical companies to make available the clinical studies of drugs sold in California, so consumers and healthcare providers could judge their safety and effectiveness.

Read letters about SB 606

Read letter CARA has written about SB 606 here.

More information about SB 606

See the CARA Legislative Committee tracking report on Calif bills.

Read LegInfo, the official legislative website, on SB 606.

(Leginfo, the Official California Legislative Information website, describes Senate and Assembly bills, with texts, current status, analyses comparing the current situation with changes a bill would make, anticipated fiscal impacts, supporting and opposing arguments and organizations, and other valuable information.)

back to CARA's priority bills.